全文获取类型
收费全文 | 4352篇 |
免费 | 245篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 89篇 |
儿科学 | 149篇 |
妇产科学 | 88篇 |
基础医学 | 400篇 |
口腔科学 | 83篇 |
临床医学 | 532篇 |
内科学 | 895篇 |
皮肤病学 | 40篇 |
神经病学 | 373篇 |
特种医学 | 117篇 |
外科学 | 904篇 |
综合类 | 82篇 |
一般理论 | 3篇 |
预防医学 | 265篇 |
眼科学 | 84篇 |
药学 | 256篇 |
中国医学 | 3篇 |
肿瘤学 | 252篇 |
出版年
2023年 | 30篇 |
2022年 | 75篇 |
2021年 | 142篇 |
2020年 | 87篇 |
2019年 | 128篇 |
2018年 | 157篇 |
2017年 | 116篇 |
2016年 | 129篇 |
2015年 | 119篇 |
2014年 | 171篇 |
2013年 | 194篇 |
2012年 | 374篇 |
2011年 | 377篇 |
2010年 | 193篇 |
2009年 | 164篇 |
2008年 | 274篇 |
2007年 | 306篇 |
2006年 | 252篇 |
2005年 | 201篇 |
2004年 | 226篇 |
2003年 | 175篇 |
2002年 | 174篇 |
2001年 | 50篇 |
2000年 | 32篇 |
1999年 | 46篇 |
1998年 | 34篇 |
1997年 | 16篇 |
1996年 | 33篇 |
1995年 | 20篇 |
1994年 | 17篇 |
1993年 | 14篇 |
1992年 | 30篇 |
1991年 | 25篇 |
1990年 | 19篇 |
1989年 | 20篇 |
1988年 | 24篇 |
1987年 | 17篇 |
1986年 | 17篇 |
1985年 | 18篇 |
1984年 | 10篇 |
1983年 | 10篇 |
1982年 | 9篇 |
1981年 | 8篇 |
1979年 | 14篇 |
1975年 | 11篇 |
1974年 | 6篇 |
1972年 | 6篇 |
1971年 | 5篇 |
1968年 | 4篇 |
1967年 | 4篇 |
排序方式: 共有4615条查询结果,搜索用时 15 毫秒
61.
62.
Melatonin modulates neonatal brain inflammation through endoplasmic reticulum stress,autophagy, and miR‐34a/silent information regulator 1 pathway
下载免费PDF全文
![点击此处可从《Journal of pineal research》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Elie Saliba Maria Cristina Albertini Sylvie Chalon Mariangela Longini Pierre Gressens Giuseppe Buonocore Walter Balduini 《Journal of pineal research》2016,61(3):370-380
Maternal infection/inflammation represents one of the most important factors involved in the etiology of brain injury in newborns. We investigated the modulating effect of prenatal melatonin on the neonatal brain inflammation process resulting from maternal intraperitoneal (i.p.) lipopolysaccharide (LPS) injections. LPS (300 μg/kg) was administered to pregnant rats at gestational days 19 and 20. Melatonin (5 mg/kg) was administered i.p. at the same time as LPS. Melatonin counteracted the LPS sensitization to a second ibotenate‐induced excitotoxic insult performed on postnatal day (PND) 4. As melatonin succeeded in reducing microglial activation in neonatal brain at PND1, pathways previously implicated in brain inflammation regulation, such as endoplasmic reticulum (ER) stress, autophagy and silent information regulator 1 (SIRT1), a melatonin target, were assessed at the same time‐point in our experimental groups. Results showed that maternal LPS administrations resulted in an increase in CHOP and Hsp70 protein expression and eIF2α phosphorylation, indicative of activation of the unfolded protein response consequent to ER stress, and a slighter decrease in the autophagy process, determined by reduced lipidated LC3 and increased p62 expression. LPS‐induced inflammation also reduced brain SIRT1 expression and affected the expression of miR‐34a, miR146a, and miR‐126. All these effects were blocked by melatonin. Cleaved‐caspase‐3 apoptosis pathway did not seem to be implicated in the noxious effect of LPS on the PND1 brain. We conclude that melatonin is effective in reducing maternal LPS‐induced neonatal inflammation and related brain injury. Its role as a prophylactic/therapeutic drug deserves to be investigated by clinical studies. 相似文献
63.
64.
65.
Arabella K. Raupach Kaylena A. Ehgoetz Martens Negar Memarian George Zhong Elie Matar Glenda M. Halliday Ronald Grunstein Simon J.G. Lewis 《Journal of sleep research》2020,29(5)
The vast majority of patients with idiopathic rapid eye movement sleep behaviour disorder will develop a neurodegenerative α‐synuclein‐related condition, such as Parkinson’s disease or dementia with Lewy bodies. The pathology underlying dream enactment overlaps anatomically with the brainstem regions that regulate circadian core body temperature. Previously, nocturnal core body temperature regulation has been shown to be impaired in Parkinson’s disease. However, no study to date has investigated nocturnal core body temperature changes in patients with idiopathic rapid eye movement sleep behaviour disorder, which may prove to be an early objective biomarker for α‐synucleinopathies. Ten healthy controls, 15 patients with idiopathic rapid eye movement sleep behaviour disorder, 31 patients with Parkinson’s disease and six patients with dementia with Lewy bodies underwent clinical assessment and nocturnal polysomnography with core body temperature monitoring. A validated cosinor method was utilised for core body temperature analysis. No differences in mesor, nadir or time of nadir were observed between groups. However, when compared with healthy controls, the amplitude of the nocturnal core body temperature (mesor minus nadir) was significantly reduced in patients with idiopathic rapid eye movement sleep behaviour disorder, Parkinson’s disease with concurrent rapid eye movement sleep behaviour disorder and dementia with Lewy bodies (p < 0.001, p = 0.043 and p = 0.017, respectively). Importantly, this relationship was not seen in those patients with Parkinson’s disease without rapid eye movement sleep behaviour disorder. In addition, there was a significant negative correlation between amplitude of the core body temperature and self‐reported rapid eye movement sleep behaviour disorder symptoms. Changes in thermoregulatory circadian rhythm may be specifically associated with the pathology underlying rapid eye movement sleep behaviour disorder rather than simply that of α‐synucleinopathy. These findings implicate thermoregulatory dysfunction as a potential early biomarker for development of rapid eye movement sleep behaviour disorder‐associated neurodegeneration, and suggest that subpopulations with differing pathological underpinnings might exist in Parkinson’s disease. 相似文献
66.
67.
68.
69.
Nicole Villafane-Ferriol George Van Buren Jose E. Mendez-Reyes Amy L. McElhany Nader N. Massarweh Eric J. Silberfein Cary Hsu Hop S. Tran Cao Carl Schmidt Nicholas J. Zyromski Mary E. Dillhoff Alexandra Roch Evelyn Oliva Alexander C. Smith Qianzi Zhang William E. Fisher 《HPB : the official journal of the International Hepato Pancreato Biliary Association》2018,20(6):514-520
Background
Although used as criterion for early drain removal, postoperative day (POD) 1 drain fluid amylase (DFA) ≤ 5000 U/L has low negative predictive value for clinically relevant postoperative pancreatic fistula (CR-POPF). It was hypothesized that POD3 DFA ≤ 350 could provide further information to guide early drain removal.Methods
Data from a pancreas surgery consortium database for pancreatoduodenectomy and distal pancreatectomy patients were analyzed retrospectively. Those patients without drains or POD 1 and 3 DFA data were excluded. Patients with POD1 DFA ≤ 5000 were divided into groups based on POD3 DFA: Group A (≤350) and Group B (>350). Operative characteristics and 60-day outcomes were compared using chi-square test.Results
Among 687 patients in the database, all data were available for 380. Fifty-five (14.5%) had a POD1 DFA > 5000. Among 325 with POD1 DFA ≤ 5000, 254 (78.2%) were in Group A and 71 (21.8%) in Group B. Complications (35 (49.3%) vs 87 (34.4%); p = 0.021) and CR-POPF (13 (18.3%) vs 10 (3.9%); p < 0.001) were more frequent in Group B.Conclusions
In patients with POD1 DFA ≤ 5000, POD3 DFA ≤ 350 may be a practical test to guide safe early drain removal. Further prospective testing may be useful. 相似文献70.